Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 843

1.

Prevalence and risk factors for human papillomavirus DNA in cervical cytology.

Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):168-71. doi: 10.1016/j.ejogrb.2011.06.021. Epub 2011 Jul 18.

PMID:
21764503
2.

Cofactors in human papillomavirus infection and cervical carcinogenesis.

Yetimalar H, Kasap B, Cukurova K, Yildiz A, Keklik A, Soylu F.

Arch Gynecol Obstet. 2012 Mar;285(3):805-10. doi: 10.1007/s00404-011-2034-3. Epub 2011 Aug 10.

PMID:
21830008
3.

Spectrum of genital human papillomavirus infection in a female adolescent population.

Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM Jr.

Sex Transm Dis. 1995 Jul-Aug;22(4):236-43.

PMID:
7482107
4.

Risk factors for cervical neoplasia in Denmark.

Kjaer SK.

APMIS Suppl. 1998;80:1-41.

PMID:
9693662
5.

Prevalence and genotype distribution of human papillomavirus in non-neoplastic cervical tissue lesion: cervical erosion.

Bayram A, Erkılıç S, Balat Ö, Ekşi F, Uğur MG, Öztürk E, Kaya G.

J Med Virol. 2011 Nov;83(11):1997-2003. doi: 10.1002/jmv.22218.

PMID:
21915876
6.

Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.

Tiews S, Steinberg W, Schneider W, Hanrath C.

J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.

PMID:
20129068
7.

Human papillomavirus and invasive cervical cancer in Brazil.

Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJ, Walboomers JM.

Br J Cancer. 1994 Jan;69(1):114-9.

8.

The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population.

Inoue M, Sakaguchi J, Sasagawa T, Tango M.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1007-13.

PMID:
16803477
9.

Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Vaccine. 2012 Jul 27;30(35):5215-21. doi: 10.1016/j.vaccine.2012.06.013. Epub 2012 Jun 17.

PMID:
22713720
10.

Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence.

Frega A, Stentella P, De Ioris A, Piazze JJ, Fambrini M, Marchionni M, Cosmi EV.

Cancer Lett. 2003 Jul 10;196(2):127-34.

PMID:
12860270
11.

Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.

PMID:
7624812
12.

Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.

Daponte A, Pournaras S, Mademtzis I, Hadjichristodoulou C, Kostopoulou E, Maniatis AN, Messinis IE.

J Clin Virol. 2006 Jul;36(3):189-93. Epub 2006 May 11.

PMID:
16690350
13.

[Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].

Levert M, Clavel C, Graesslin O, Masure M, Birembaut P, Quereux C, Gabriel R.

Gynecol Obstet Fertil. 2000 Oct;28(10):722-8. French.

PMID:
11244634
14.

Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.

Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC.

Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):104-9.

PMID:
15950365
15.

The relationship between contraceptives, sexual practices, and cervical human papillomavirus infection among a college population.

Burkett BJ, Peterson CM, Birch LM, Brennan C, Nuckols ML, Ward BE, Crum CP.

J Clin Epidemiol. 1992 Nov;45(11):1295-302.

PMID:
1331341
16.

Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.

Uberti-Foppa C, Origoni M, Maillard M, Ferrari D, Ciuffreda D, Mastrorilli E, Lazzarin A, Lillo F.

J Med Virol. 1998 Oct;56(2):133-7.

PMID:
9746069
17.

[Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].

Serra H, Pista A, Figueiredo P, Urbano A, Avilez F, De Oliveira CF.

Acta Med Port. 2000 Jul-Aug;13(4):181-92. Portuguese.

18.

Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.

Kovács K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, Schmitt C, Pajor L, Bollmann R.

J Med Virol. 2008 Oct;80(10):1814-23. doi: 10.1002/jmv.21282.

PMID:
18712836
19.

Detection of human papillomavirus in cervical biopsies of summer camp ROTC cadets with abnormal papanicolaou smears.

Stafford EM, Stewart RS Jr, Teague GR, Gomez RR, Crothers BA, Michel TJ, Patience TH, Moore DC.

J Pediatr Adolesc Gynecol. 1996 Aug;9(3):119-24.

PMID:
8795786
20.

Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.

Tonon SA, Picconi MA, Zinovich JB, Liotta DJ, Bos PD, Galuppo JA, Alonio LV, Ferreras JA, Teyssié AR.

Infect Dis Obstet Gynecol. 1999;7(5):237-43.

Supplemental Content

Support Center